Two doctors on the front lines of the fight against COVID-19 return to discuss the current state of the global pandemic, from the promising vaccine news, to their cutting-edge antibody-treatment study recently published in the New England Journal of Medicine, to the brutal winter that awaits. Dr. Gregory Huhn, a Chicago-based infectious disease specialist, and Dr. Ajay Nirula, Eli Lilly’s VP of Immunology, also assess the impending changes under the Biden Administration, the need for attitudinal shifts regarding science and the realistic timeline for a return to packed stadiums, music festivals, Thanksgiving gatherings… and some semblance of normalcy.